|
Volumn 85, Issue 6, 2014, Pages 709-710
|
Potential disease-modifying effects of selective serotonin reuptake inhibitors in multiple sclerosis: Systematic review and meta-analysis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ESCITALOPRAM;
FLUOXETINE;
GADOLINIUM;
PAROXETINE;
PLACEBO;
SEROTONIN UPTAKE INHIBITOR;
CONTRAST ENHANCEMENT;
CONTROLLED STUDY;
DISEASE ACTIVITY;
DISEASE COURSE;
DROWSINESS;
DRUG TOLERABILITY;
DYSTHYMIA;
FATIGUE;
HEADACHE;
HUMAN;
LETTER;
MAJOR DEPRESSION;
META ANALYSIS;
MULTIPLE SCLEROSIS;
NAUSEA;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SOMNOLENCE;
SYSTEMATIC REVIEW;
TREATMENT OUTCOME;
DEPRESSION;
MULTIPLE SCLEROSIS;
QUALITY OF LIFE;
ANTIDEPRESSIVE AGENTS;
DEPRESSION;
DEPRESSIVE DISORDER, MAJOR;
HUMANS;
INCIDENCE;
MULTIPLE SCLEROSIS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RECURRENCE;
SEROTONIN UPTAKE INHIBITORS;
|
EID: 84899988250
PISSN: 00223050
EISSN: 1468330X
Source Type: Journal
DOI: 10.1136/jnnp-2013-306829 Document Type: Letter |
Times cited : (12)
|
References (5)
|